MeiraGTx Holdings (MGTX) Enterprise Value (2018 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Enterprise Value came in at -$65.9 million in Q4 2025, up 36.4% YoY from -$48.3 million in Q4 2024, and down 344.25% on a QoQ basis from -$14.8 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Enterprise Value (2018 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Enterprise Value data on file, last reported at -$65.9 million in Q4 2025.
- Quarterly Enterprise Value rose 36.4% year-over-year to -$65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65.9 million (up 36.4% YoY) and the FY2025 annual result came in at -$65.9 million, up 36.4% from the prior year.
- Enterprise Value fell to -$65.9 million in Q4 2025, from -$14.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$14.8 million in Q3 2025 to a low of -$199.4 million in Q1 2021.
- A 5-year average of -$102.8 million and a median of -$108.7 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 94.14% — and 2025, when it soared 88.13%.
- Tracing MGTX's Enterprise Value over 5 years: stood at -$137.7 million in 2021, then climbed by 16.11% to -$115.5 million in 2022, then dropped by 13.1% to -$130.6 million in 2023, then climbed by 20.66% to -$103.7 million in 2024, then jumped by 36.4% to -$65.9 million in 2025.
- The last three Enterprise Value figures came in at -$65.9 million (Q4 2025), -$14.8 million (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Dec 31, 2025 | 578.98 Mn |
| Sep 30, 2025 | 647.51 Mn |
| Jun 30, 2025 | 492.34 Mn |
| Mar 31, 2025 | 471.93 Mn |
| Dec 31, 2024 | 373.78 Mn |
| Sep 30, 2024 | 198.96 Mn |
| Jun 30, 2024 | 171.30 Mn |
| Mar 31, 2024 | 270.03 Mn |
| Dec 31, 2023 | 315.83 Mn |
| Sep 30, 2023 | 228.22 Mn |
| Jun 30, 2023 | 307.30 Mn |
| Mar 31, 2023 | 181.84 Mn |
| Dec 31, 2022 | 200.56 Mn |
| Sep 30, 2022 | 261.31 Mn |
| Jun 30, 2022 | 266.35 Mn |
| Mar 31, 2022 | 505.46 Mn |
| Dec 31, 2021 | 919.89 Mn |
| Sep 30, 2021 | 440.46 Mn |
| Jun 30, 2021 | 514.24 Mn |